Breaking News
Gene-editing Therapy CTX-001 Granted Priority Medicines Designation for Severe SCD in EU
Iranian Blood Transfusion Organization Newsletter
COVID-19 Update: Here’s Where We Stand Now In the Race For A Vaccine
eThalED Webinar Series: Heart Disease in Thalassaemia
TIF’s Latest Newsletter Issue Is Out!
TIF Newsletter – August 2020
Revisiting The Use and Management of Blood in Europe in Times of Crisis and Beyond
AstraZeneca Resumes Final Stage Trials For Its Covid-19 vaccine After Initial Halt
The ”International Blood Diseases Symposium” Is Just Around The Corner
Coming Up: A TIF Live Webinar on ”Heart Disease in Thalassaemia”
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
TIF
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country work
Projects
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
RSS
Instagram
YouTube
Twitter
Facebook
Gene-editing Therapy CTX-001 Granted Priority Medicines Designation for Severe SCD in EU
COVID-19 Update: Here’s Where We Stand Now In the Race For A Vaccine
TIF’s Latest Newsletter Issue Is Out!
Revisiting The Use and Management of Blood in Europe in Times of Crisis and Beyond
AstraZeneca Resumes Final Stage Trials For Its Covid-19 vaccine After Initial Halt
The ”International Blood Diseases Symposium” Is Just Around The Corner
Highlights
TIF e-Academy
COVID-19 Pandemic
Clinical Trial Updates
Renzo Galanello Fellowships
International Thalassaemia Day
The Thalia Project
Back to top button
Close
Search for
Close
Log In
Forget?
Remember me
Log In
Cookies
This site uses cookies.
Find out more
Okay, thanks
